Related Experiment Video

Updated: Apr 7, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.9K

A Metabolism-Informed Neural Network Identifies Pathways Influencing the Potency and Toxicity of Antimicrobial

Harkirat Singh Arora1, Katherine Lev2, Aaron Robida3

  • 1Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48105 USA.

Npj Drug Discovery
|April 6, 2026
PubMed

Insights

CALMA, a computational framework, optimizes antimicrobial drug combinations by analyzing potency and toxicity. It significantly reduces experimental screening, identifying safer and more effective treatments for drug resistance.

Area of Science:

  • Computational biology
  • Pharmacology
  • Microbiology

Background:

  • Antimicrobial resistance is a critical global health challenge.
  • Current combination therapy screening is costly and inefficient, often yielding suboptimal results.
  • Developing novel antimicrobial strategies is essential.

Purpose of the Study:

  • To introduce CALMA, a computational framework for analyzing multi-drug combination potency and toxicity.
  • To enhance the interpretability and efficiency of identifying effective antimicrobial combinations.
  • To reduce the experimental search space for optimal drug combinations.

Main Methods:

  • CALMA integrates genome-scale metabolic modeling with a neural network incorporating metabolic subsystems.
  • The framework quantitatively analyzes the potency-toxicity landscape of drug combinations.
  • It leverages metabolic architecture to improve model generalizability and reduce parameters.

Main Results:

  • CALMA reduced the experimental search space for optimal combinations by 97%.
  • Identified promising combinations against *Escherichia coli* and *Mycobacterium tuberculosis* with reduced toxicity.
  • Uncovered the nucleotide salvage pathway's role in selective toxicity, validated in vitro.
  • Analysis of 400,000+ patient records showed decreased kidney side-effects with a CALMA-identified vancomycin combination.

Conclusions:

  • CALMA offers a rational, mechanistic approach to streamline antimicrobial combination design.
  • The framework significantly enhances efficiency and safety in discovering new drug therapies.
  • This computational strategy holds promise for combating antimicrobial resistance.
Keywords:
Computational biology and bioinformaticsDrug discovery

More Related Videos

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry07:28

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry

Published on: October 29, 2020

9.6K

Related Concept Videos

Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
131
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.6K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
176
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
69
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
172
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
344